Identification of Calpain 10 Isoforms (b, d, e, f & h) Conserved Regions and Possible Functional Prophecy through Bioinformatics


 Cysteine proteases, calpain 10 isoforms, conserved domain homology, structure function prediction, action mechanism, Type diabetes, insulin secretion.
Type 2 diabetes

How to Cite

Kausar Saboohi, Samina Bano, & Bushra Chaudhry. (2013). Identification of Calpain 10 Isoforms (b, d, e, f & h) Conserved Regions and Possible Functional Prophecy through Bioinformatics. Journal of Basic & Applied Sciences, 9, 489–495.


Calpain 10 is an atypical calpain ubiquitously exist in all human tissues. It exhibits eight protein isoforms designated as “a-h” which play a vital role in glucose homeostasis but actual mechanism of action is yet to be ascertained. We have predicted the partial roles of Isoform a, c and g previously. They were envisaged to act partially as mu and m-calpain cysteine proteases. Here we predict the function of minor isoforms b, d, e, f and h. We have applied NCBI Blast and Conserved domain tool for nucleotide and protein alignments. Blast query indicated 87%, 84%, 87%, 94% and 34% identity of isoform b, d, e, f and h with canonical sequence of calpain 10 a isoform. Conserved domain analyses of protein sequences revealed significant structural similarities of their N-terminal domain I and II with catalytic domain of cysteine protease superfamily PC1 (e-value:CAPN10b, d, e = 2.41e-76, CAPN10f = 1.07e-43 and CAPN10h = 1.13e-17). Isoform b, d and e have one consecutive domain similar with C2 like subdomain III (e-value=2.92-32, 1.03e-35, 1.88e-14 respectively) and was classified in CAPN10 group of Palb subfamily. Isoform f and h were lacking this domain and had shorter sequences. Although structural similarities are not guaranteed for similar actions but domain homology predicted the existence of similar functions as of calpain I and II.


Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000; 26: 163-75.

Arrington DD, Van Vleet TR, Schnellmann RG. Calpain 10: a mitochondrial calpain and its role in calcium-induced mitochondrial dysfunction. Am J Physiol Cell Physiol 2006; 291: C1159-71.

Smith MA, Covington MD, Schnellmann RG. Loss of calpain 10 causes mitochondrial dysfunction during chronic hyperglycemia. Arch Biochem Biophys 2012; 523: 161-8.

Akopova OV, Sagach VF. Effect of Ca2+ on induction of the mitochondrial pore opening in the rat myocardium. Ukr Biokhim Zh 2004; 76: 48-55.

Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307: 384-7.

Norton L, Parr T, Chokkalingam K, et al. Calpain-10 gene and protein expression in human skeletal muscle: effect of acute lipid-induced insulin resistance and type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 992-8.

Aron Marchler-Bauer JBA, Farideh Chitsaz, Myra K. et al. "CDD: specific functional annotation with the Conserved Domain Database." Nucleic Acids Res 2009: 205-10.

Marchler-Bauer A, Lu S, Anderson JB, et al. CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Res 2011; 39(Suppl 1): D225-D9.

Marchler-Bauer A, Bryant SH. CD-Search: protein domain annotations on the fly. Nucleic Acids Res 2004; 32(Suppl 2): W327-W31.

Turner MD, Cassell PG, Hitman GA. Calpain-10: from genome search to function. Diabetes Metab Res Rev 2005; 21: 505-14.

Covington MD, Schnellmann RG. Chronic high glucose down regulates mitochondrial calpain 10 and contributes to renal cell death and diabetes-induced renal injury. Kidney Intl 2012; 81: 391-400.

Franco SJ, Huttenlocher A. Regulating cell migration: calpains make the cut. J Cell Sci 2005; 118(Pt 17): 3829-38.

Croall DE, Ersfeld K. The calpains: modular designs and functional diversity. Genome Biol 2007; 8: 218.

Tompa P, Emori Y, Sorimachi H, Suzuki K, Friedrich P. Domain III of calpain is a Ca2+-regulated phospholipid-binding domain. Biochem Biophys Res Commun 2001; 280: 1333-9.

Reverter D, Strobl S, Fernandez-Catalan C, Sorimachi H, Suzuki K, Bode W. Structural basis for possible calcium-induced activation mechanisms of calpains. Biol Chem 2001; 382: 753-66.

Moldoveanu T, Hosfield CM, Lim D, Elce JS, Jia Z, Davies PL. A Ca(2+) switch aligns the active site of calpain. Cell 2002; 108: 649-60.

Strobl S, Fernandez-Catalan C, Braun M, et al. The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proceed Nat Acad Sci 2000; 97: 588-92.

Saunders JE, Beeson CC, Schnellmann RG. Characteri-zation of functionally distinct mitochondrial subpopulations. J Bioenerg Biomembr 2013; 45: 87-99.

Smith MA, Schnellmann RG. Calpains, mitochondria, and apoptosis. Cardiovascr Res 2012.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2013 Journal of Basic & Applied Sciences